Combinations of pyrimidylaminobenzamide bcr-abl inhibitors...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/506 (2006.01) A61K 31/436 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2615254

The invention provides a pharmaceutical combination comprising: a) a pyrimidylaminobenzamide compound, and b) an mTOR kinase inhibitor and a method for treating or preventing a proliferative disease using such a combination.

L'invention concerne une combinaison pharmaceutique comprenant : a) un composé de pyrimidylaminobenzamide, et b) un inhibiteur de kinase mTOR, ainsi qu'une méthode de traitement ou de prévention d'une maladie proliférative à l'aide de ladite combinaison.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combinations of pyrimidylaminobenzamide bcr-abl inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combinations of pyrimidylaminobenzamide bcr-abl inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of pyrimidylaminobenzamide bcr-abl inhibitors... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1442556

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.